PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Jan-2024 Samsung Biologics Reports Fourth Quarter and Fiscal Year 2023 Financial Results Samsung Biologics
24-Jan-2024 Pharmapack Report Predicts Major Innovation for Inhaled Pulmonary and Intra Nasal Drug Delivery in 2024 Pharmapack by CPHI
24-Jan-2024 Lynx.MD Builds Massive Gastroenterology (GI) Data Repository for Research and AI Development AccessWire
24-Jan-2024 Singapore Advanced Therapy Drug Manufacturer GDMC Secures US$21 Million Growth Capital Funding to Expand Global Genetic Medicines Design and Manufacturing Operations GDMC
24-Jan-2024 HealthJoy Names Marc Salois as Chief Revenue Officer AccessWire
24-Jan-2024 Extended Perfusion Time of Livers Can Streamline Planning and Logistics - Enabling More Liver Transplants to be Performed During Daytime AccessWire
24-Jan-2024 Cloud DX Signs Contract for Remote Care Monitoring with VHA Home HealthCare AccessWire
24-Jan-2024 Throtle Names Chris Neuner as Company President AccessWire
24-Jan-2024 Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch AccessWire
24-Jan-2024 SingleTimeMicroneedles, Inc. Selected as Finalist for 2024 SXSW Pitch Newswire
24-Jan-2024 ZetrOZ Systems to Demonstrate sam Wearable Ultrasound Unit at Las Vegas Conference AccessWire
24-Jan-2024 Ainos Announces $1.75 Million Follow-On Funding AccessWire
24-Jan-2024 Neptune Retains Stifel to Explore Strategic Alternatives for Sprout Organics AccessWire
24-Jan-2024 SingleTimeMicroneedles, Inc. Selected as Finalist for 2024 SXSW Pitch AccessWire
24-Jan-2024 Emergency Care Partners Establishes a New Partner Group in Missouri AccessWire
24-Jan-2024 Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets EVAXION
24-Jan-2024 Otsuka announces topline results from Ionis’ Phase 3 OASIS-HAE study of investigational donidalorsen in patients with hereditary angioedema Otsuka Pharmaceutical Europe Ltd
24-Jan-2024 LEO Pharma announces positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE) LEO Pharma
24-Jan-2024 LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals LEO Pharma
24-Jan-2024 Lexaria Releases Annual Letter from the CEO AccessWire